Benfit from more than 15 years in-depth experience as specialty CRO for ultra sensitive immunoassays beyond the scope of what is usually considered feasible.

Understanding the critical role of ultra sensitive bioanalysis in development of novel therapeutics, Chimera Biotec is committed to provide support for all phases of the drug development process.

Make use of our services in:

  • Pre-clinics: Biomarker, PK, Immunogenicity, Microsampling
  • Phase I-IV: Biomarker, PK, Immunogenicity, Microsampling, Multi-Center Trial Support
  • Single PK-Assay throughout all phases; Pre-clinics to Phase IV

From "proof of concept" over ICH GCP to full GLP compliancy, all desired and required regulatory regimes are available.